M. Molteni et al., ANTITHYROID ANTIBODIES IN ITALIAN SCLERODERMA PATIENTS - ASSOCIATION OF ANTITHYROID PEROXIDASE (ANTI-TPO) ANTIBODIES WITH HLA-DR15, Clinical and experimental rheumatology, 15(5), 1997, pp. 529-534
Objective: To evaluate the frequency of anti-thyroid antibodies in a g
roup of patients with scleroderma (SSc) and to analyze their genetic a
ssociation with the HLA class II antigens. Methods: Anti-thyroglobulin
(anti-TG) and anti-thyroid peroxidase (anti-TPO) antibodies were meas
ured by hemagglutination techniques. Thyroid function was evaluated by
determining the levels of FT3, FT4 and TSH. HLA-DR typing was carried
out using a standard complement-dependent microlymphocytotoxicity tes
t. Results: The proportions of patients with anti-TG and anti-TPO anti
bodies were 12% (10/85) and 19% (16/85) respectively. Two patients wit
h anti-thyroid antibodies had overt hypothyroidism and shared the HLA-
DR3 allele. The SSc subjects with anti-TPO antibodies showed a higher
frequency of the HLA-DR15 allele than the patients without these antib
odies. Conclusion: A considerable number of patients with scleroderma
have antibodies to thyroid antigens without exhibiting any alterations
of their thyroid function. HLA-DR15 is all immunogenic marker for the
formation of antibodies against microsomal thyroid peroxidase.